Sage Journals: Discover world-class research

Retricted access

Research article

First published 2006-7

Fosamprenavir: Drug Development for Adherence

E Kelly Hester, Haley V Chandler, Kelli M Sims

Annals of Pharmacotherapy

Retricted access

Research article

First published 2008-8

Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection

L Calza, R Manfredi, D Pocaterra [...]

International Journal of STD & AIDS

Retricted access

Research article

First published 2012-3

Long-term efficacy and safety of once-daily fosamprenavir 1400 mg boosted by ritonavir 100 mg: the BOLD100 study

G Blick, P Greiger-Zanlungo, S Gretz [...]

International Journal of STD & AIDS

Free access

Case report

First published 2008-7

Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients

Federico Pea, Marcello Tavio, Federica Pavan [...]

Antiviral Therapy

Free access

Announcement

First published 2007-8

Amprenavir and Lopinavir Pharmacokinetics following Coadministration of Amprenavir or Fosamprenavir with Lopinavir/Ritonavir,with or without Efavirenz

Paul A Pham, Craig W Hendrix, Patricia Barditch-Crovo [...]

Antiviral Therapy

Free access

Research article

First published 2010-11

Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men

Paul A Randell, Akil G Jackson, Marta Boffito [...]

Antiviral Therapy

Retricted access

Letter

First published 2009-6

Favourable use of non-boosted fosamprenavir in patients treated with warfarin

H Honda, H Gatanaga, J Matsumura [...]

International Journal of STD & AIDS

Retricted access

Research article

First published 2009-04

Comparison of Once-Daily Fosamprenavir Boosted with Either 100 or 200 mg of Ritonavir,in Combination with Abacavir/Lamivudine: 96-Week Results from COL100758

Charles B. Hicks, Edwin DeJesus, Louis M. Sloan [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2011-07

Liver Toxicity of Antiretroviral Combinations Including Fosamprenavir Plus Ritonavir 1400/100 mg Once Daily in HIV/Hepatitis C Virus-Coinfected Patients

Nicolás Merchante, Luis F. López-Cortés, Marcial Delgado-Fernández [...]

AIDS Patient Care and STDs

Retricted access

Research article

First published 2010-04

Impact of Low Abundance HIV Variants on Response to Ritonavir-Boosted Atazanavir or Fosamprenavir Given Once Daily with Tenofovir/Emtricitabine in Antiretroviral-Naive HIV-Infected Patients

Lisa L. Ross, Winkler G. Weinberg, Edwin DeJesus [...]

AIDS Research and Human Retroviruses

Search results